| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
272,940
|
273,604
|
327,352
|
296,861
| | Cost of Revenue | 219,058 | 218,588 | 261,953 | 235,556 | | |
Gross Profit
|
53,882
|
55,016
|
65,399
|
61,305
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 27,693 | 29,105 | 27,635 | 31,228 |
|
Non Recurring |
-
| 1,032 | 9,480 | 1,958 |
|
Others | 23,636 | 23,866 | 23,925 | 19,381 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
2,553
|
1,013
|
4,359
|
8,738
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (1,473) | (1,062) | (458) | (24,290) |
|
Earnings Before Interest And Taxes | 1,080 | (49) | 3,901 | (15,552) |
|
Interest Expense | 11,199 | 11,403 | 11,257 | 12,144 |
|
Income Before Tax | (10,119) | (11,452) | (7,356) | (27,696) |
|
Income Tax Expense | 3,163 | 3,046 | 2,189 | 5,342 |
|
Minority Interest | (173) | (70) | (243) | (271) |
|
|
|
Net Income From Continuing Ops | (13,455) | (14,568) | (9,788) | (57,543) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(13,455)
|
(14,568)
|
(9,788)
|
(57,543)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(13,455)
|
(14,568)
|
(9,788)
|
(33,309)
|
|